D-VALNEB-500 MG TABLET | DIVAPROEX PROLONGED RELEASE 500 MG
D-VALNEB-500 MG TABLET contains Divaproex Prolonged Release 500 mg, prescribed for epilepsy, bipolar disorder, and migraine prevention. Use only under medical supervision for optimal results.
D-VALNEB-500 MG TABLET – Prolonged-Release Neurological Care
Product Summary
D-VALNEB-500 MG TABLET contains Divaproex Prolonged Release 500 mg, an anticonvulsant and mood-stabilizing medicine used to manage epilepsy, bipolar disorder, and help prevent migraine headaches. Its prolonged-release formulation delivers the medicine gradually throughout the day, providing sustained therapeutic levels and supporting convenient once-daily dosing under medical supervision.
Product Full Description
D-VALNEB-500 MG TABLET is formulated with Divaproex Prolonged Release 500 mg, a well-established medicine used in neurology and psychiatry. It is prescribed to control various seizure disorders, stabilize mood in bipolar disorder, and prevent recurrent migraine attacks. The prolonged-release technology allows gradual drug release, helping maintain consistent blood concentrations over an extended period. By regulating abnormal electrical activity in the brain and enhancing inhibitory neurotransmission, it supports long-term symptom control. D-VALNEB-500 MG TABLET should always be taken according to the advice of a qualified healthcare professional.
Usage Instructions
Take D-VALNEB-500 MG TABLET exactly as prescribed by your doctor.
Swallow the prolonged-release tablet whole with water.
Do not crush, chew, or split the tablet, as this may interfere with the prolonged-release mechanism.
It may be taken with or without food, preferably at the same time each day.
Continue taking the medicine for the full prescribed duration.
Do not discontinue treatment without consulting your healthcare provider.
Medicinal Advantages
D-VALNEB-500 MG TABLET offers several important therapeutic benefits:
Helps control various types of epileptic seizures.
Supports long-term mood stabilization in bipolar disorder.
Assists in preventing recurrent migraine headaches.
Provides sustained drug release for prolonged therapeutic action.
Helps maintain stable medication levels with convenient dosing.
Widely recommended in neurological and psychiatric clinical practice guidelines when prescribed appropriately.
Mechanism of Action
D-VALNEB-500 MG TABLET contains Divaproex Prolonged Release, which is converted into valproic acid after absorption. It increases the availability of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter that helps reduce excessive nerve activity in the brain. The medicine also stabilizes neuronal membranes by influencing sodium and calcium channels, helping control abnormal electrical impulses responsible for seizures while contributing to mood stabilization and migraine prevention.
Off-Label Uses
Under specialist supervision, D-VALNEB-500 MG TABLET may occasionally be prescribed for:
Certain behavioral disorders requiring mood stabilization
Impulse control disorders in selected patients
Schizoaffective disorder with mood symptoms
Aggression associated with specific neurological or psychiatric conditions
Other neurological conditions as determined by a specialist
Off-label use should always be based on careful clinical evaluation.
Expert Advice
Take D-VALNEB-500 MG TABLET at the same time every day.
Swallow the prolonged-release tablet whole without crushing or chewing.
Attend regular medical follow-up appointments for ongoing assessment.
Inform your healthcare provider about all medicines, supplements, and existing medical conditions.
Follow your prescribed dosage carefully and never adjust it without medical advice.
Continue therapy even if symptoms improve unless instructed otherwise by your physician.
Precautions
1. Do Not Crush or Chew the Tablet
D-VALNEB-500 MG TABLET is a prolonged-release formulation. Crushing or chewing the tablet may alter the release profile and reduce treatment effectiveness.
2. Regular Medical Monitoring
Your doctor may recommend periodic blood tests and clinical evaluations during long-term therapy to monitor treatment progress and ensure appropriate dosing.
3. Pregnancy Planning
Women who are pregnant or planning pregnancy should consult their healthcare provider before using D-VALNEB-500 MG TABLET, as treatment decisions require careful medical assessment.
4. Inform Your Doctor About Liver or Kidney Disease
Patients with liver disorders, kidney impairment, or metabolic conditions should discuss their complete medical history before starting treatment to allow appropriate monitoring.
5. Do Not Stop Treatment Suddenly
Abrupt discontinuation may interfere with seizure control or mood stabilization. Always follow your doctor's instructions when adjusting or discontinuing therapy.
Storage Conditions
Store D-VALNEB-500 MG TABLET below 25°C.
Keep the tablets in their original blister packaging.
Protect from moisture, direct sunlight, and excessive heat.
Store in a cool and dry place.
Keep out of reach of children and pets.
Do not use after the expiry date printed on the package.
Frequently Asked Questions (FAQs)
1. What is D-VALNEB-500 MG TABLET used for?
It is prescribed for the management of epilepsy, bipolar disorder, and the prevention of migraine headaches under medical supervision.
2. What is the active ingredient in D-VALNEB-500 MG TABLET?
Each prolonged-release tablet contains Divaproex Prolonged Release 500 mg.
3. Can I crush or split D-VALNEB-500 MG TABLET?
No. The tablet should be swallowed whole to preserve its prolonged-release properties.
4. Can D-VALNEB-500 MG TABLET be taken with food?
Yes. It may be taken with or without food unless otherwise advised by your doctor.
5. Is D-VALNEB-500 MG TABLET suitable for long-term use?
Yes. Many patients use it long term under regular medical supervision, depending on their condition.
6. What should I do if I miss a dose?
Take the missed dose as soon as you remember. If it is close to your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses together.
7. Is D-VALNEB-500 MG TABLET a prescription medicine?
Yes. It should only be taken with a valid prescription and under the supervision of a qualified healthcare professional.
8. Why is the prolonged-release formulation important?
The prolonged-release formulation gradually releases the medicine throughout the day, helping maintain stable therapeutic levels and supporting consistent symptom control.
Suggested Product Tags
D-VALNEB-500 MG TABLET
DIVAPROEX PROLONGED RELEASE TABLET 500 MG
Divaproex Sodium PR Tablet
Divaproex 500 mg
Prolonged Release Tablet
Anticonvulsant Medicine
Epilepsy Treatment
Bipolar Disorder Medication
Migraine Prevention
Mood Stabilizer
Neurology Medicine
Prescription Medicine
Seizure Control
CNS Medication
Mental Health Medicine
Oral Prolonged Release Tablet
